10-QPeriod: Q1 FY2015

Globalstar, Inc. Quarterly Report for Q1 Ended Mar 31, 2015

Filed May 8, 2015For Securities:GSAT

Summary

Globalstar, Inc.'s first quarter 2015 performance showed a modest increase in total revenue to $21.0 million, up from $20.5 million in the prior year period. This growth was primarily driven by a $0.9 million increase in service revenue, largely from gains in the Duplex, SPOT, and Simplex subscriber bases. However, this was partially offset by a decrease in subscriber equipment sales, impacted by rebate programs and a stronger U.S. dollar. The company reported a significant net loss of $129.7 million, an improvement from a loss of $250.5 million in Q1 2014, largely due to a substantial reduction in derivative loss. Operating expenses decreased due to lower depreciation and amortization, but marketing, general, and administrative expenses rose, driven by subscriber acquisition costs and stock compensation. The company ended the quarter with $13.7 million in cash and cash equivalents, with $14.0 million available under its equity line with Terrapin. Despite improvements in some operational areas, the company continues to grapple with substantial debt and significant derivative liabilities impacting its financial results.

Financial Statements
Beta

Key Highlights

  • 1Total revenue increased by 2% to $21.0 million in Q1 2015, driven by a 7% rise in service revenue primarily from increased Duplex, SPOT, and Simplex subscribers.
  • 2Net loss narrowed significantly to $129.7 million from $250.5 million in Q1 2014, primarily due to a substantial decrease in derivative losses.
  • 3Operating expenses decreased by 7% to $38.2 million, largely due to lower depreciation, amortization, and accretion expenses.
  • 4Marketing, general, and administrative expenses increased by 11% to $8.6 million, attributed to higher subscriber acquisition costs and stock compensation.
  • 5Cash and cash equivalents increased to $13.7 million at the end of Q1 2015, up from $7.1 million at the end of 2014, supported by financing activities.
  • 6The company has $14.0 million remaining under its equity line with Terrapin, which was used as an "Equity Cure Contribution" in February 2015 to assist with financial covenant compliance.
  • 7Significant derivative liabilities, totaling $548.5 million, continue to impact the balance sheet and statement of operations, with a $107.9 million loss recognized in the quarter.

Frequently Asked Questions